CIK 0001557746 · Non-accelerated filer<br>Smaller reporting company
Aclaris Therapeutics, Inc.
Sign in to watch- Ticker
- ACRS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 460571712
- Phone
- 484-324-7933
- Business address
- 701 LEE ROAD, SUITE 103, WAYNE, PA, 19087
- UPLOAD Other SEC-generated Letter
- S-3 Offering Registration Statement
- 10-K Report Annual Report
- 8-K Event Results of operations
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes INTERIM CEO gave up 3,559 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Scientific Officer gave up 11,317 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 5,816 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Business Officer gave up 15,447 shares (to pay taxes)
- 8-K Event Regulation FD disclosure
- 4 Shares withheld for taxes Chief Scientific Officer gave up 41,851 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 38,221 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Business Officer gave up 40,664 shares (to pay taxes)
- 4 Shares withheld for taxes INTERIM CEO gave up 17,436 shares (to pay taxes)
- EFFECT Other Notice of Effectiveness
- 424B3 Offering Prospectus
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
Page 6 of 44 · 872 filings